Photodynamic therapy (PDT) is a treatment indicated for patients with Wet Age Related Macular Degeneration. Your doctor can determine if you qualify for PDT by fluorescein angiogram.

PDT uses a combination of Visudyne, a light activated drug, and the light from a non-thermal laser (a laser that does not burn the retina). Visudyne is administered  intravenously, and after administration, the IV is removed, and the non-thermal laser is directed on the abnormal blood vessels, activating the visudyne within the eye. PDT is beneficial in that it can destroy abnormal blood vessels from wet ARMD, without damaging the normal tissues of the retina. The goal of Visudyne therapy is to stabilize patient's vision. PDT will not restore vision lost to wet ARMD, but treatment may confine and inhibit the progression of the disease.

Patients who have undergone PDT are advised to follow strict post operative guidelines.  The Visudyne is administered through out the whole body, thus making the patient light sensitive for 5 days after the treatment.  Any exposed skin to sunlight, or hallogen lights will cause a third degree burn.